Investor Presentation • Mar 11, 2022
Investor Presentation
Open in ViewerOpens in native device viewer
INTERNAL Datalogic Confidential
This document has been prepared by Datalogic S.p.A. (the "Company") for use during meetings with investors and financial analysts and is solely for information purposes. The information set out herein has not been verified by an independent audit company. Neither the Company nor any of its subsidiaries, affiliates, branches, representative offices (the "Group"), as well as any of their directors, officers, employees, advisers or agents (the "Group Representatives") accepts any responsibility for/or makes any representation or warranty, express or implied, as to the accuracy, timeliness or completeness of the information set out herein or any other related information regarding the Group, whether written, oral or in visual or electronic form, transmitted or made available. This document may contain forward-looking statements about the Company and/or the Group based on current expectations and opinions developed by the Company, as well as based on current plans, estimates, projections and projects of the Group. These forward-looking statements are subject to significant risks and uncertainties (many of which are outside the control of the Company and/or the Group) which could cause a material difference between forward-looking information and actual future results. The information set out in this document is provided as of the date indicated herein. Except as required by applicable laws and regulations, the Company assumes no obligation to provide updates of any of the aforesaid forward-looking statements. Under no circumstances shall the Group and/or any of the Group Representatives be held liable (for negligence or otherwise) for any loss or damage howsoever arising from any use of this document or its contents or otherwise in connection with the document or the aforesaid forward-looking statements. This document does not constitute an offer to sell or a solicitation to buy or subscribe to Company shares and neither this entire document or a portion of it may constitute a recommendation to affect any transaction or to conclude any legal act of any kind whatsoever.
This document may not be reproduced or distributed, in whole or in part, by any person other than the Company. By viewing and/or accepting a copy of this document, you agree to be bound by the foregoing limitations.
REVENUES €166.1 +25.1% +22.4% Net FX
.
❑ Adj EBITDA margin improved by 2.1pts vs 2020 at 14.3% despite rising inflationary challenges, not yet fully offset by price increases in the second half of the year.
❑ R&D spending* at 9.6% on revenues, confirming the Group's Innovation roadmap.
* Including capitalized R&D expenses and excluding D&A
❑ EMEAI: leading Group's performance in 2021 at +32.8% Net FX. Sound growth across all countries. Spain, France and the
❑ Americas: Group's second-largest market, achieved growth of +15.1% Net FX. T&L and MFG expansion as primary drivers of the
| €m | 2021 FY |
2020 FY |
% Var |
% Var Net FX |
|---|---|---|---|---|
| EMEAI | 337 | 254 | 6% | 8% |
| 8 | 8 | 32 | 32 | |
| Americas | 167 | 151 | 9% | 1% |
| 7 | 2 | 10 | 15 | |
| APAC | 95 | 73 | 28 | 27 |
| 0 | 8 | 8% | 6% | |
❑ Retail: double digit performance in APAC +23.9% and EMEAI +10.0% offsetting the slowdown in the US market.
❑ Manufacturing: +48.4% Net FX with solid growth in Automotive, Packaging and Food & Beverage. The acquisition of the MD Group
❑ Healthcare: stable with positive trends, especially in EMEAI and APAC, in the hospital sectors and in pharmaceutical distribution.
❑ Channel: Sales to small/medium-size customers largely benefited from the economic recovery (+29.3%) mainly in Americas and
| €m | 2021 FY |
2020 FY Restated* |
% Var |
% Var Net FX |
|---|---|---|---|---|
| Retail | 210 | 198 | 2% | 7% |
| 5 | 2 | 6 | 7 | |
| Manufacturing | 165 | 111 | 3% | 4% |
| 7 | 8 | 48 | 48 | |
| & | 81 | 53 | 0% | 52 |
| Transportation | 2 | 8 | 51 | 6% |
| Logistics | ||||
| Healthcare | 16 | 16 | (1 | 0 |
| 2 | 5 | 6%) | 2% | |
| Channel | 109 | 84 | 29 | 30 |
| 1 | 4 | 3% | 9% | |
| Total | 582 | 464 | 25 | 26 |
| Business | 7 | 6 | 4% | 6% |
| DL | ||||
| Informatics | 18 | 16 | 0% | 4% |
| 9 | 4 | 15 | 18 | |
| division Intra |
(1 1) |
(1 2) |
||
| Total Datalogic |
600 5 |
479 8 |
25 2% |
26 4% |
*December 31, 2020, comparative data have been restated following the reorganisation of the commercial function launched in 2020.
* Including capitalized R&D expenses and excluding D&A
❑ R&D spending* at 9.6%. Commitment to Product Development Roadmap continues
Investigator – new release
.
| € m |
FY 2021 |
FY 2020 |
% Var |
|---|---|---|---|
| Revenues | 600 5 |
479 8 |
2% 25 |
| Margin Gross |
257 6 |
220 0 |
|
| % Revenues on |
42 9% |
8% 45 |
2 9 pp - |
| Operating expenses |
(200 7) |
(185 8) |
|
| % Revenues on |
(33 4%) |
(38 7%) |
3 +5 pp |
| Adjusted EBITDA |
85 7 |
58 3 |
|
| Adj Ebitda % margin |
3% 14 |
2% 12 |
+2 1 pp |
| EBIT | 47 0 |
18 4 |
|
| Ebit % margin |
8% 7 |
8% 3 |
0 +4 pp |
| Result Net |
39 5 |
13 9 |
|
| % Revenues on |
6% 6 |
9% 2 |
+3 7 pp |
€ m
.
* Including IFRS 16 impact
▪ Under the current geopolitical context and the sharpening of the shortage, Revenue growth and Ebitda % expected in single digit range in the first half of the year
▪ With solid order backlog and actions undertaken to reduce electronic components shortages and related cost, higher sales' conversion and strong margin recovery expected in the second half of the year.
IR Manager Laura Bernardelli Tel. +39 051 3147109 [email protected] Via Candini, 2 40012 Lippo di Calderara di Reno Bologna – Italy
IR Advisor Vincenza Colucci CDR Communication Srl Tel. +39 335 6909547 [email protected]
IR Assistant Daniela Giglioli Tel. +39 051 3147109 Fax +39 051 3147205 [email protected]
www.datalogic.com
March 22, 2022 STAR Conference Milan
April 29, 2022 Shareholders' Meeting
May 12, 2022 Q1 2022 Results This presentation contains statements that are neither reported financial results nor other historical information. These statements are forward-looking statements. These forward-looking statements rely on a number of assumptions and are subject to a number of risks and uncertainties, many of which are outside the control of Datalogic S.p.A., that could cause actual results to differ materially from those expressed in or implied by such statements, such as future market conditions, currency fluctuations, the behavior of other market participants and the actions of governmental and state regulators
© 2019 Datalogic S.p.A. and/or its affiliates - All rights reserved. • Without limiting the rights under copyright, no part of this documentation may be reproduced, stored in or introduced into a retrieval system, or transmitted in any form or by any means, or for any purpose, without the express written permission of Datalogic S.p.A. and/or its affiliates • Datalogic and the Datalogic logo are registered trademarks of Datalogic S.p.A. in many countries, including the U.S. and the E.U. • All other trademarks and brands are property of their respective owners.
Via Candini, 2 - 40012 Lippo di Calderara di Reno - Bologna (Italy) Tel. +39 051 3147011 | Fax +39 051 3147205 [email protected] ww.datalogic.com
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.